SCHEMBL27999947

SCHEMBL27999947

O=C(Cl)OC(c1ccccc1)N1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.53
LMNA P02545 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 2/20 0.50
CYP1A2 P05177 5/20 0.49
CYP2C9 P11712 5/20 0.49
CYP2C19 P33261 5/20 0.49
CYP3A4 P08684 4/20 0.49
CYP2D6 P10635 4/20 0.49
KCNA5 P22460 4/20 0.49
KCNH2 Q12809 4/20 0.49
KCNE1 P15382 1/20 0.49
HPGD P15428 2/20 0.47
MAPK1 P28482 1/20 0.47
KDM4E B2RXH2 2/20 0.45
MAPT P10636 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TSHR P16473 2/20 0.43
CHRM2 P08172 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28086157 0.98 LMNA (0.51) GAALMNAKMT2AALDH1A1MEN1
Hydrochloric Acid SCHEMBL28314858 0.97 LMNA (0.54) GAALMNAKMT2AALDH1A1MEN1
SCHEMBL28049253 0.95 LMNA (0.47) GAALMNAKMT2AALDH1A1MEN1
SCHEMBL28822692 0.86 GAA (0.40) GAALMNAKMT2AALDH1A1MEN1
SCHEMBL27995211 0.85 ATM (0.41) GAALMNAKMT2AALDH1A1MEN1
SCHEMBL28816744 0.84 MEN1 (0.51) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL27968133 0.84 ATM (0.38) GAALMNAKMT2AALDH1A1MEN1
SCHEMBL9392253 0.84 GAA (0.53) GAALMNAKMT2AALDH1A1MEN1
SCHEMBL10254763 0.84 KMT2A (0.54) GAALMNAKMT2AALDH1A1MEN1
SCHEMBL28299375 0.83 KCNA3 (0.43) GAALMNAALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110072857-A 1, 3-disubstituted cyclobutanone or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2019-07-30 CN claimed
CN-105473554-B Condensed piperidine amide as ion channel modulators 沃泰克斯药物股份有限公司 2019-08-13 CN disclosed
CN-110072857-A 1, 3-disubstituted cyclobutanone or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2019-07-30 CN disclosed
CN-110036004-A Inhibitors of cyclin dependent kinase 7(CDK7) 希洛斯医药品股份有限公司 2019-07-19 CN disclosed
CN-109879859-A COT regulator and its application method 吉利德科学公司 2019-06-14 CN disclosed
CN-107922390-B COT modulators and methods of use thereof 吉利德科学公司 2019-05-10 CN disclosed
CN-109415355-A Benzdioxan derivative and its medicinal usage 奥赖恩公司 2019-03-01 CN disclosed
CN-109053742-A New tricyclic compound ABBVIE 公司 2018-12-21 CN disclosed
CN-103958506-B 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH 诺华股份有限公司 2017-02-22 CN disclosed
CN-105555778-A Cyclic amine derivative and pharmaceutical use thereof TORAY INDUSTRIES 2016-05-04 CN disclosed
CN-105473554-A Fused piperidine amides as modulators of ion channels VERTEX PHARMA 2016-04-06 CN disclosed
CN-102918042-B 8-methyl-1-phenyl-imidazo [1,5-a ] pyrazine compounds MERCK SHARP & DOHME B.V. (NL) 2016-03-09 CN disclosed
CN-104955824-A Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants GENENTECH INC 2015-09-30 CN disclosed
CN-102827067-B Beta-lactamase inhibitor SCHERING CORPORATION (US) 2015-09-23 CN disclosed
CN-104812748-A Dihydropyrazole GPR40 modulators BRISTOL MYERS SQUIBB CO 2015-07-29 CN disclosed
CN-101679266-B PIM kinase inhibitors and methods of their use NOVARTIS AG 2015-05-06 CN disclosed
CN-104379560-A Benzamide derivative CHUGAI PHARMACEUTICAL CO LTD 2015-02-25 CN disclosed